rf-fullcolor.png

 

April 4, 2012
by Alexander Gaffney, RAC

Health Canada Announces Fee Changes For Drugs, Devices

Health Canada released a bevy of guidance documents updating the fee structures for pharmaceutical products and medical devices.

"Health Canada would like to inform sponsors that the following documents have been revised to reflect fees that are current as of 1 April 2012," the agency said in a statement.

The fees for devices and pharmaceutical products reflect a 2% increase "as well as other minor revisions to improve clarity" of various guidance documents.

The agency updated the following documents:


Read more:

Health Canada - Notice on revisions made to guidance documents and forms

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.